Aesthetic Injectables Market Size

Aesthetic Injectables Market was valued at USD 13.2 billion in 2023 and is anticipated to showcase a growth of 10.2% to reach USD 31.3 billion by 2032. Aesthetic injectables refer to non-surgical cosmetic procedures that involve injecting substances into the skin to enhance or alter its appearance. These procedures are often performed for aesthetic purposes to address concerns such as wrinkles, fine lines, volume loss, and facial contouring among others.

The growth of the aesthetic injectables market is propelled by several factors, including the increasing aging population seeking non-surgical solutions for signs of aging, rising beauty consciousness across age groups, ongoing technological advancements for improving product safety and efficacy, and the minimally invasive nature of these procedures. According to International Society of Aesthetic Plastic Surgery, around 7.3 million non-surgical botulinum toxin procedures were performed. Thus, the growing awareness of aesthetic procedures and the availability of non-surgical options have contributed to an expanding patient base seeking injectable treatments.